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Background: Results from clinical studies on acupuncture for stroke rehabilitation are contradictory. The reason for
the inconsistent findings especially lie in the transparency and accuracy of randomized controlled trials (RCTs)
reports. This study aims to analyze the quality of reporting and its correlates in RCTs on acupuncture for stroke
rehabilitation.
Methods: Quality of reporting for included papers was assessed against a subset of criteria adapted from the
CONSORT 2010 statement and STRICTA. An overall quality score (OQS) and a combined key methodological index
score (MIS) was calculated for each trial. Then, factors associated with OQS and MIS were identified.
Results: A total of 15 RCTs were included in full text. The median OQS based on the CONSORT statement and
STRICTA was 8 and 12, respectively. The significant predictors for CONSORT OQS was funding source, for STRICTA
was year of publication. With regard to the MIS, no variable was associated with improved methodological quality.
Conclusions: Our study found that the overall quality of reporting on RCTs of acupuncture for stroke rehabilitation
was general or good. But some items’ reporting was found where information was insufficient or inadequate in
most studies which needed substantial improvement.
Keywords: Acupuncture, Quality of reporting, Randomized controlled trials (RCTs), Stroke rehabilitation, The
CONSORT statement, STRICTABackground
Stroke is a leading cause of death in both middle- and
high-income countries, responsible for 22% of all deaths
worldwide [1]. The risk factors leading to increasing
stroke incidence are an aging population, dietary changes,
and work-related stress, etc. In China, stroke is the second
most common cause of death in cities and the third most
common cause of death in rural areas [2]. Also, stroke is a
major cause of disability and dependency. Poststroke dis-
ability with a high incidence (>50%) brings a heavy burden
to patients and their caregivers [3]. In the United States,
the total societal and healthcare costs have risen from
$53.6 billion in 2004 [4] to $68.9 billion in 2009 [3].
Clearly, patients with stroke urgently need safe and effect-
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reproduction in any medium, provided the orpeople to search for conventional treatment to improve
the effect of stroke rehabilitation, such as acupuncture.
For more than 3000 years, practitioners in China have
used acupuncture to treat various diseases, including the
sequelae of stroke. Acupuncture is widely used to improve
motor, sensation, speech and other neurological functions
in patients with stroke. Compared to other conventional
interventions, acupuncture is relatively simple, inexpen-
sive and safe which has been well accepted by Chinese
patients and also increasingly practiced in some Western
countries [5]. Results from clinical studies on acupuncture
for stroke rehabilitation, however, are contradictory. Al-
though some reviews indicate that too little evidence
exists to prove the efficacy of acupuncture for stroke pa-
tients [6-9], a series of studies suggest that this modality is
an effective method for improving disabilities due to
stroke [10-13]. Researchers have called the quality of these
meta-analyses into question, however, and the likely po-
tential for publication bias suggests a need for additional
research on the subject. Currently, it is necessary tol Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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trials (RCTs) of acupuncture for stroke rehabilitation, for
quality of reporting is essential for guiding journal peer-
review decisions, for experts’ recommendations, and to
conduct unbiased meta-analysis, as it influences our inter-
pretation of evidence.
The Consolidated Standards for Reporting Trials
(CONSORT) statement developed in 1996 [14] aimed to
facilitate critical appraisal and interpretation of RCTs by
authors, providing them guidance about how to improve
the reporting of their trials, as well as by peer reviewers
and editors, helping them identify reports with potentially
biased results. The CONSORT statement has been further
revised and is published as the CONSORT 2010 state-
ment. Combined with the CONSORT statement, the
acupuncture-specific Standards for Reporting Interven-
tions in Controlled Trials of Acupuncture (STRICTA)
were designed to help authors fully report the acupuncture
intervention in clinical trials [15,16]. The combination of
both tools helps us evaluate the completeness and trans-
parency of RCTs reports on acupuncture for stroke re-
habilitation according to their items.
However, to the best of our knowledge, there are no
data about the quality of RCTs reporting in acupuncture
for stroke rehabilitation. The present study aims to (i)
describe the characteristics of published RCTs reports
on acupuncture for stroke rehabilitation; (ii) assess the
overall quality and key methodological items of published
articles of RCTS on acupuncture for stroke rehabilitation;
and (iii) determine factors associated with better reporting
quality.Methods
Search strategy
We searched the Cochrane Stroke Group Trials Register
(March 2013), the Chinese Stroke Trials Register (March
2013), the Chinese Acupuncture Trials Register (March
2013) and the Trials Register of the Cochrane Comple-
mentary Medicine Field (March 2013). In addition, we
searched the following bibliographic databases: MED-
LINE (1966 to March 2013), EMBASE (1980 to March
2013), CINAHL (1982 to March 2013), AMED (the Al-
lied and Complementary Medicine Database, 1985 to
March 2013), the Chinese Biological Medicine Database
(CBM-disc, 1979 to March 2013), China National Know-
ledge Infrastructure (CNKI, 1979 to March 2013), Wanfang
databases (1982 to March 2013) and VIP database (1992
to March 2013). The following search terms were used
in Chinese and English: poststroke, hemorrhagic, ischemic,
cerebrovascular disorders, acupuncture, electro-acupuncture,
needle, scalp acupuncture, auricular acupuncture, acu-
puncture point, meridian, acupoint and point injec-
tion, etc.Inclusion & exclusion criteria
Types of studies
RCTs comparing acupuncture with at least one control
group that used placebo, sham treatment or conventional
treatment in patients with subacute (one to three months
since onset) or chronic stroke (over three months since
onset) were included in this research. RCTs were included
if invasive acupuncture was used as the sole intervention
or as an adjunct to another standard treatment for stroke
rehabilitation and if the control group received the same
concomitant treatments as the acupuncture group. A
randomization sequence generated from a random num-
ber table, calculator or computerized random number
generator was considered authentic.
Types of participants
Patients of any gender, sex or ethnicity with ischemic or
hemorrhagic stroke in the subacute or chronic phases
were eligible. Stroke must be diagnosed according to the
World Health Organization definition (rapidly developed
clinical signs of focal (or global) disturbances of cerebral
function, lasting more than 24 hours or leading to death,
with no other apparent cause than of vascular origin
[17]; or magnetic resonance imaging (MRI) or confirmed
by computerized tomography (CT ).
Types of interventions
Acupuncture therapy will be defined as body acupunc-
ture, scalp acupuncture, electro-acupuncture, warm
needling, or ear acupuncture, etc. Studies that compare
different types of acupuncture were excluded. Placebo
acupuncture refers to a needle attached to the skin sur-
face (not penetrating the skin but at the same acupoints)
[18]. Sham acupuncture refers to: 1) a needle placed in
an area close to but not in the acupuncture points [18];
2) subliminal skin electro stimulation via electrodes at-
tached to the skin [19].
Assessment of quality of reporting
Rating of overall reporting quality
An overall quality score (OQS) with 15 items from the
CONSORT 2010 statement [20] and 17 items from the
STRICTA [21,22] were used (Table 1). Each item was
scored 1 if it was reported and 0 if it was not clearly, or
definitely not stated. The CONSORT discussion section
items were excluded because we considered them too
subjective to evaluate.
Rating of key methodological items
Concealment of allocation, appropriate blinding (either
practitioner, participant or assessor), and analysis ac-
cording to intention-to-treat (ITT) principle are highly
related to potential sources of systematic bias and thus
distortion in the estimation of the effect. Consequently,
Table 1 Overall quality of reporting rating using items from the CONSORT Statement (n = 15)
Item Criteria Description No. of
positive
trials
% 95% CI Cohen’s к
coefficient
95% CI
1 “Randomized” in the
title or abstract
Study identified as a randomized controlled
in the title or abstract
15 100 - 1.00 -
2 Background Adequate description of the scientific background
and explanation of rationale
12 80 57 to 100 0.74 0.50 to 0.98
3 Trial design Description of trial design (such as parallel, factorial)
including allocation ratio
10 67 40 to 94 0.71 0.45 to 1.00
4 Participants Description of the eligibility criteria for participants 13 87 67 to 100 0.78 0.40 to 1.00
5 Interventions Details of the interventions intended for each group 11 73 48 to 99 0.82 0.70 to 1.00
6 Outcomes Definition of primary (and secondary when appropriate)
outcome measures
4 27 1 to 52 0.85 0.75 to 0.99
7 Sample size Description of sample size calculation 2 13 −6 to 33 0.83 0.68 to 1.00
8 Randomization Description of the method used to generate the random
sequence
9 60 32 to 88 0.76 0.60 to 0.99
12 Statistical methods Description of the statistical methods used to compare groups
for primary outcomes, subgroup analyses, or adjusted analyses
11 73 48 to 99 0.73 0.40 to 1.00
13 Flow chart Details on the flow of participants through each stage of
the trials (No. of patients randomly assigned, receiving
intended treatment, completing the protocol and analyzed)
5 33 6 to 60 0.84 0.68 to 1.00
14 Recruitment Dates defining the periods of recruitment and follow-up 6 40 12 to 68 0.65 0.38 to 0.99
15 Baseline data An outline of baseline demographic and clinical
characteristics of each group
14 93 79 to 100 0.68 0.42 to 1.00
17 Outcomes and
estimation
For each primary and secondary outcome, a summary
of results for each group is given, and the estimated
effect size and its precision (e.g. 95% CI)
4 27 1 to 52 0.75 0.52 to 1.00
18 Ancillary analyses Clear statement of whether subgroup/adjusted analyses
were prespecified or exploratory
3 20 −3 to 43 0.68 0.35 to 0.99
19 Harms Description of all important adverse events in each group 5 33 6 to 60 0.85 0.72 to 1.00
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the CONSORT 2010 Statement have been assessed separ-
ately. We then developed three “yes”/”no” items, so that
emphasis was placed on quality of reporting rather than
adequacy of trial design. A combined key methodological
index score (MIS) was calculated for each trial by combin-
ing the scores of these three factors (range, 0 to 3).
Data extraction & analysis
Each article was reviewed by two independent investiga-
tors. They extracted useful information by modified CON-
SORT and STRICTA checklists (Table 1, 2 and 3). After
both raters finished their review, we calculated Cohen’s
к-statistics to assess agreement between two reviewers.
Agreement was judged as poor if к≤ 0.20; fair if 0.20
lower than к≤ 0.40; moderate if 0.40 lower than к≤ 0.60;
substantial if 0.60 lower than к≤ 0.80; good if к higher
than 0.80; and perfect if к = 1. Discrepancies were
reviewed in detail and subsequently settled by consensus.
To identify factors associated with the overall quality
of publications, we used the OQS as the outcome variable
which was modeled using linear regression. Only variables
that were significant at P≤ 0.10 in the univariate modelswere used in a multivariate regression model for selecting
significant variables (P ≤ 0.05). To identify factors associ-
ated with methodological quality, we used the MIS as the
outcome variable in the regression analyses. As the out-
come variable can be considered as a count, we relied
on ordinal regression model and adjusted the variance
empirically.
Linear and ordinal regression analysis was performed
using SPSS version 20.0. Database of RCTs in acupuncture
for stroke rehabilitation are provided in Additional file 1
and 2.Results
The RCTs selection process is outlined in Figure 1. After
identification, screening, eligibility determining of the lit-
eratures, a total of 15 relevant RCTs were included in the
final analysis.Characteristics of the included trials
Year distribution of publication
Counting the number of articles, frequency, which refers
to acupuncture for stroke rehabilitation in RCTs, was
Table 2 Overall quality of reporting rating using items from STRICTA (n = 15)
Item Criteria Description No. of
positive
trials





(1a) Style of acupuncture (e.g., Traditional Chinese Medicine, Japanese,
Korean, Western medical, Five Element, ear acupuncture, etc.)
12 80 57 to 100 0.65 0.38 to 0.98
(1b) Reasoning for treatment provided, based on historical context,
literature sources and/or consensus methods, with references where
appropriate
12 80 57 to 100 0.78 0.60 to 1.00
(1c) Extent to which treatment was varied 10 67 40 to 94 0.72 0.48 to 0.95
2 Details of
needling
(2a) Number of needle insertions per subject per session
(mean and range where relevant)
10 67 40 to 94 0.75 0.60 to 0.99
(2b) Names (or location if no standard name) of points used
(uni-/bilateral)
12 80 57 to 100 0.83 0.65 to 1.00
(2c) Depth of insertion, based on a specified unit of measurement or
on a particular tissue level
8 53 25 to 82 0.92 0.81 to 1.00
(2d) Responses sought (e.g., de qi or muscle twitch response) 9 60 32 to 88 0.63 0.38 to 1.00
(2e) Needle stimulation (e.g., manual or electrical) 13 87 67 to 100 0.74 0.50 to 0.99
(2f) Needle retention time 14 93 79 to 100 0.78 0.62 to 1.00
(2 g)Needle type (diameter, length and manufacturer or material) 10 67 40 to 94 0.70 0.53 to 1.00
3 Treatment
regimen
(3a) Number of treatment sessions 10 67 40 to 94 0.62 0.33 to 0.98




(4a) Details of other interventions administered to the acupuncture
group (e.g., moxibustion, cupping, herbs, exercises, lifestyle advice)
3 20 −3 to 43 0.85 0.68 to 0.99
(4b) Setting and context of treatment, including instructions to
practitioners, and information and explanations to patients
5 33 6 to 60 0.64 0.35 to 0.98
5 Practitioner
background
(5) Description of participating acupuncturists (qualification or
professional affiliation, years in acupuncture practice, other relevant
experience)




(6a) Rationale for the control or comparator in the context of the
research question, with sources that justify the choice(s)
9 60 32 to 88 0.78 0.65 to 1.00
(6b) Precise description of the control or comparator. If sham
acupuncture or any other type of acupuncture-like control is used,
provide details as for items 1–3 above
9 60 32 to 88 0.73 0.56 to 1.00
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to 8 (53.33%) in 2007-December, 2012.Publication language
Of the 15 RCT papers, 10 (66.67%) were written in
English. The remaining 5 papers (33.33%) were pub-
lished in Chinese.Nationality of authors
A total of 7 (46.67%) included papers were written by
authors in Chinese research institutes; 7 (46.67%) were
reported by international researchers; the remaining one
paper (6.66%) was collaborations of Chinese and inter-
national researchers.Funding source
Seven articles (46.67%) reported their sources of funding.
Funding was obtained from provincial/municipal or inter-
national institutes.
Choice of comparator interventions
Interventions of nine trials (60.0%) comprised of sole
acupuncture, followed by acupuncture plus other therapies
(6 reports; 40.0%).
Quality of reporting
Rating of overall reporting quality
The ratings of overall quality of reporting based on the
CONSORT statement were listed in Table 1. When the
15 RCTs were considered, the median OQS was 8, with
Table 3 Reporting quality of key methodological items (n = 15)
Item Criteria Description No. of
positive
trials





Description of the method used to implement the random allocation
sequence assuring the concealment until interventions are assigned
5 33 6 to 60 0.68 0.45 to 1.00
11 Blinding Whether or not participants, those administering the interventions, or
those assessing the outcomes were blinded to group assignment
9 60 32 to 88 0.75 0.52 to 1.00
16 Intent-to-
treat analysis
No. of participants in each group included in each analysis and whether
it was done by “intention to treat”
5 33 6 to 60 0.82 0.68 to 1.00
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existed in terms of “outcomes”, “sample size”, “outcomes
and estimation”, “ancillary analyses” with positive rate of
less than 30% (Table 1). All of the items had a substan-
tial, good or perfect agreement (Table 1).
The ratings of overall quality of reporting based on
STRICTA were listed in Table 2. When the 15 RCTs
were considered, the median OQS was 12, with a mini-
mum of 3 and a maximum of 16. Poor reporting existed
in terms of “4a: Details of other interventions” and “4b:
Setting and context of treatment” with positive rate of
20% and 33% (Table 2). All of the items had a substantial
or good agreement (Table 2).Figure 1 Diagram flow of the randomized controlled trials articles selRating of key methodological items
Allocation concealment, blinding, and analysis by intent
to treat were reported in 5 (33%), 9 (60%), and 5 (33%)
of the 15 RCTs, respectively (Table 3). The median MIS
was 1 with a minimum of 0 and a maximum of 3
(Table 3). Among the 15 studies, 5 (33%) did not report
any of the three key methodological items. All of the
items had a substantial or good agreement (Table 3).
Exploratory analysis: factors associated with better
reporting quality
In univariate analyses, nationality of authors and funding
source were associated with an increased OQS based onection process.
Table 5 Univariate analysis for factors associated with
better OQS from STRICTA (n = 15)
Variables β S.E. t P 95% CI
Constant −958.16 446.54 −2.15 0.05 −1922.84 ~ 6.53
Year of publication 0.48 0.22 2.17 0.05 0.00 ~ 0.96
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variate linear regression model suggested that funding
source remained independent and significant predictors
of overall quality. Specifically, the mean OQS based on
the CONSORT statement increased by about 4.05 for
manuscripts with funding source (95% CI, 0.44 to 7.67;
P < 0.05) (Table 4).
In univariate analyses, only year of publication was asso-
ciated with an increased OQS based on STRICTA. Specif-
ically, the mean OQS based on STRICTA increased by
about 0.48 for manuscripts published in the period of one
year increment (95%CI, 0.00 ~ 0.96; P ≤ 0.05) (Table 5).
With regard to the MIS, in ordinal regression analyses,
no variable was associated with improved methodological
quality (P > 0.05).
Discussion
To the best of our knowledge, this study is the first inves-
tigation on the quality of reporting on RCTs of acupunc-
ture for stroke rehabilitation according to the revised
CONSORT and STRICTA guidelines. We found evidence
that quality of reporting of the overall CONSORT items
was general with median OQS 8 which was more than
half of its total score 15; quality of reporting of the
STRICTA items was good with median OQS 12 which
was more than 70% of its total score 17; however, it is
poor quality for the reporting of key methodological items
with median MIS 1 which was 33% of its total score. Simi-
lar results were reported in some published studies
[23,24]. Some studies found that the quality of reporting
in RCTs on Chinese medicine remained poor (mainly in
key methodological items), but had improved over time
[25,26]. None of the variables we looked at in our ordinal
regression model were significant predictors of improved
methodological quality. We noted that the overall OQS
based on the CONSORT Statement was correlated with
funding source and STRICTA score was correlated with
year of publication.
The purpose of reporting guidelines such as CON-
SORT and STRICTA is to increase the transparency of
study methods and ultimately improve the overall qual-
ity of research. However, poorly reported trials make it
ambiguous for other readers to assess the validity of the
results and may mislead medical policy-makers in their
decisions. Our study found that the overall quality of
reporting was general or good between 1997 to MarchTable 4 Multivariate linear regression analysis for factors
associated with better OQS from the CONSORT statement
(n = 15)
Variables β S.E. t P 95% CI
Constant 2.32 2.59 0.90 0.39 −3.28 ~ 7.92
Funding source 4.05 1.67 2.43 0.03 0.44 ~ 7.672013. There might be multiple reasons. First, most of in-
cluded reports are published after 2001 when STRICTA
and revised CONSORT statement was published, espe-
cially, STRICTA score was correlated with year of publi-
cation. In the evaluation of acupuncture trials performed
by Prady et al. [27], the authors concluded that reporting
of CONSORT items had improved after the introduction
of CONSORT but that the introduction of STRICTA did
not improve the reporting of STRICTA items. However,
another evaluation of auriculotherapy trials [23] came to
similar conclusions with ours. Maybe the introduction of
STRICTA and CONSORT statement improved the over-
all quality of reporting in our research. Second, more
and more clinicians were training in study design and
reporting of RCTs, and some better quality research pa-
pers had been submitted and published in international
journals which had a more rigorous peer-review process.
Our finding that the overall OQS based on the CON-
SORT statement was correlated with funding source, also
suggested clinical trials with funding have more capacity
to provide assurance for the better quality of study design
and reporting of RCTs.
However, some items’ reporting was found where in-
formation was insufficient or inadequate in most stud-
ies. These areas are as follows: “allocation concealment”,
“analysis by intent to treat”, “outcomes”, “sample size”,
“outcomes and estimation“ and “ancillary analyses”
based on the CONSORT statement; “details of other inter-
ventions” and “setting and context of treatment” based on
STRICTA.
A generated allocation schedule should be implemented
by using allocation concealment, a critical mechanism that
prevents foreknowledge of treatment assignment and thus
shields those who enroll participants from being influenced
by this knowledge [20]. Trials in which the allocation se-
quence had been inadequately or unclearly concealed
yielded larger estimates of treatment effects than did trials
in which authors reported adequate allocation conceal-
ment. Intention to treat was defined as the inclusion of all
patients randomly assigned in the analysis, regardless of
whether they actually satisfied the entry criteria, the treat-
ment actually received, and subsequent withdrawal or
protocol deviations [25,27]. ITT is generally favored be-
cause it avoids bias associated with non-random loss of
participants. Unfortunately, we found only 33% of the
trial reports provided a description of ITT or allocation
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ity of their findings.
Authors should indicate how the sample size and pri-
mary outcome was determined. Theoretically, clinical sig-
nificant difference between interventions was detected by
a high power if a trial had enough number of subjects.
The researcher should note the primary and second out-
come on which the calculation was based. For each primary
and secondary outcome, results for each group, the esti-
mated effect size and its precision (e.g. 95% confidence
interval) presentation were recommended. However, no
more than 30% of included reports presented the primary
and second outcome, sample size calculation and outcome
estimation, etc.
As for STRICTA, “details of other interventions” referred
to the auxiliary techniques, prescribed self-treatment and
lifestyle advice provided by the practitioner. All additional
components, whether carried out by the practitioner or pa-
tient and whether integral or adjunctive to the acupuncture
needling, should be described clearly [21]. “Setting and
context of treatment” could also provide important add-
itional components to treatment. For patients, the context
factor includes some information given by practitioners
might modify the trial’s outcome; for practitioners, it in-
cludes some instructions given by patients after prescribing
or proscribing explanations to them might modify practi-
tioners’ normal practice [21]. But the number of reports
provided this information was small. As different acupunc-
turists providing treatment to different treatment arms will
influence generalisability of the trial results, the details of
other interventions and the background of both groups
should be explained.
One limitation we should point out is that, due to lan-
guage barrier, we didn’t search for any manuscripts pub-
lished in non- Chinese or English journals. This is an
area for worthwhile future study. It remains unknown
whether searching in other language journals would have
altered the constitution of our sample or results.
Conclusions
Our study found that the overall quality of reporting on
RCTs of acupuncture for stroke rehabilitation was general
or good. however, it is poor quality for the reporting of key
methodological items. our results stress the need for re-
searchers involved in RCTs of acupucture for stroke to im-
prove the methodological quality of their research through
the introduction of STRICTA and CONSORT statement.
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